-
Lublin FD, Haring DA, Ganjgahi H, Ocampo A, et al.
How patients with multiple sclerosis acquire disability. Brain 2022.
-
Huber H, Edenhofer S, von Tresckow J, Robrecht S, et al.
Phase 2 study of obinutuzumab (GA-101), ibrutinib and venetoclax (CLL2-GIVe) in
patients with untreated high-risk chronic lymphocytic leukemia. Blood 2021.
-
Morrison SL, Han G, Elenwa F, Vetto JT, et al.
Is the presence of tumor-infiltrating lymphocytes predictive of outcomes in
patients with melanoma? Cancer 2022.
-
Tortorella C, Aiello A, Gasperini C, Agrati C, et al.
Humoral- and T-Cell-Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in
Patients With MS Using Different Disease-Modifying Therapies. Neurology 2022;98:e541-e554.
-
Rivard L, Friberg L, Conen D, Healey JS, et al.
Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International
Collaboration. Circulation 2022;145:392-409.
|